Zhitong Finance App News, Kehua Biotech (002022.SZ) issued an announcement. Recently, the company and its holding subsidiary Suzhou Tianlong Biotechnology Co., Ltd. (hereinafter referred to as “Suzhou Tianlong”) received a medical device registration certificate (in vitro diagnostic reagent) issued by the State Drug Administration. Drugs involved: “Chlamydia trachomatis nucleic acid detection kit (PCR-fluorescence method)” and “parainfluenza virus nucleic acid detection kit (fluorescence PCR method)”.

Zhitong Finance App News, Kehua Biotech (002022.SZ) issued an announcement. Recently, the company and its holding subsidiary Suzhou Tianlong Biotechnology Co., Ltd. (hereinafter referred to as “Suzhou Tianlong”) received a medical device registration certificate (in vitro diagnostic reagent) issued by the State Drug Administration. Drugs involved: “Chlamydia trachomatis nucleic acid detection kit (PCR-fluorescence method)” and “parainfluenza virus nucleic acid detection kit (fluorescence PCR method)”.